Direct Meds
Direct Meds provides compounded GLP-1 medications in both injectable and sublingual drop formats, offering an alternative for patients who prefer non-injection options. With semaglutide sublingual drops starting around $179/month, the platform emphasizes telehealth access and multiple delivery formats.
Overview
- Consultation Model
- Async Telehealth
- Headquarters
- Remote
- Shipping
- 5-7 business days
- Lab Testing
- No
- Prescriber Info
- Licensed providers conduct telehealth evaluations before prescribing
- Founded
- 2023
Pros
- Sublingual drop option — no injections required
- Multiple medication formats (injectable + drops)
- Competitive pricing on sublingual options
- Both semaglutide and tirzepatide available
Cons
- Compounded medications only — not FDA-approved
- No insurance accepted
- Limited clinical support beyond prescribing
- Injectable pricing higher than some competitors
- Relatively new with limited reviews